Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside.
Sardu C, Massetti M, Scisciola L, Trotta MC, Santamaria M, Volpicelli M, Ducceschi V, Signoriello G, D'Onofrio N, Marfella L, Casolaro F, Amico MD', Ruocco A, Balestrieri ML, Mauro C, Rafaniello C, Capuano A, Paolisso G, Marfella R. Sardu C, et al. Among authors: signoriello g. Pharmacol Res. 2022 Aug;182:106303. doi: 10.1016/j.phrs.2022.106303. Epub 2022 Jun 10. Pharmacol Res. 2022. PMID: 35697289 Free article.
Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study.
Sasso FC, Marfella R, Pagano A, Porta G, Signoriello G, Lascar N, Minutolo R, Carbonara O, Persico M, Piscione F, De Nicola L, Torella R, Paolisso G. Sasso FC, et al. Among authors: signoriello g. Acta Diabetol. 2015 Apr;52(2):239-47. doi: 10.1007/s00592-014-0623-x. Epub 2014 Aug 11. Acta Diabetol. 2015. PMID: 25109286 Clinical Trial.
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment.
Marfella R, Sardu C, Calabrò P, Siniscalchi M, Minicucci F, Signoriello G, Balestrieri ML, Mauro C, Rizzo MR, Paolisso G, Barbieri M. Marfella R, et al. Among authors: signoriello g. Diabetes Obes Metab. 2018 Mar;20(3):723-729. doi: 10.1111/dom.13122. Epub 2017 Nov 3. Diabetes Obes Metab. 2018. PMID: 28950045
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis.
Marfella R, Sardu C, Balestrieri ML, Siniscalchi M, Minicucci F, Signoriello G, Calabrò P, Mauro C, Pieretti G, Coppola A, Nicoletti G, Rizzo MR, Paolisso G, Barbieri M. Marfella R, et al. Among authors: signoriello g. Diabetol Metab Syndr. 2018 Jan 3;10:1. doi: 10.1186/s13098-017-0304-3. eCollection 2018. Diabetol Metab Syndr. 2018. PMID: 29308090 Free PMC article.
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up.
Sardu C, Barbieri M, Balestrieri ML, Siniscalchi M, Paolisso P, Calabrò P, Minicucci F, Signoriello G, Portoghese M, Mone P, D'Andrea D, Gragnano F, Bellis A, Mauro C, Paolisso G, Rizzo MR, Marfella R. Sardu C, et al. Among authors: signoriello g. Cardiovasc Diabetol. 2018 Nov 29;17(1):152. doi: 10.1186/s12933-018-0795-8. Cardiovasc Diabetol. 2018. PMID: 30497513 Free PMC article.
Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up.
Sardu C, Barbieri M, Balestrieri ML, Siniscalchi M, Paolisso P, Calabrò P, Minicucci F, Signoriello G, Portoghese M, Mone P, D'Andrea D, Gragnano F, Bellis A, Mauro C, Paolisso G, Rizzo MR, Marfella R. Sardu C, et al. Among authors: signoriello g. Cardiovasc Diabetol. 2018 Dec 27;17(1):159. doi: 10.1186/s12933-018-0804-y. Cardiovasc Diabetol. 2018. PMID: 30591048 Free PMC article.
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin.
Sardu C, D'Onofrio N, Torella M, Portoghese M, Loreni F, Mureddu S, Signoriello G, Scisciola L, Barbieri M, Rizzo MR, Galdiero M, De Feo M, Balestrieri ML, Paolisso G, Marfella R. Sardu C, et al. Among authors: signoriello g. Cardiovasc Diabetol. 2019 Sep 30;18(1):126. doi: 10.1186/s12933-019-0931-0. Cardiovasc Diabetol. 2019. PMID: 31570103 Free PMC article.
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts.
Marfella R, D'Onofrio N, Trotta MC, Sardu C, Scisciola L, Amarelli C, Balestrieri ML, Grimaldi V, Mansueto G, Esposito S, D'Amico M, Golino P, Signoriello G, De Feo M, Maiello C, Napoli C, Paolisso G. Marfella R, et al. Among authors: signoriello g. Metabolism. 2022 Feb;127:154936. doi: 10.1016/j.metabol.2021.154936. Epub 2021 Nov 18. Metabolism. 2022. PMID: 34801581 Free article. Clinical Trial.
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study.
Sardu C, Massimo Massetti M, Rambaldi P, Gatta G, Cappabianca S, Sasso FC, Santamaria M, Volpicelli M, Ducceschi V, Signoriello G, Paolisso G, Marfella R. Sardu C, et al. Among authors: signoriello g. Metabolism. 2022 Dec;137:155243. doi: 10.1016/j.metabol.2022.155243. Epub 2022 Jun 19. Metabolism. 2022. PMID: 35732222 Free article.
133 results